ArticleHeliyon2024

Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer.

Panpan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.